Allgens Medical Technology CO., LTD. (SHA:688613)
24.28
+0.16 (0.66%)
Jan 23, 2026, 3:00 PM CST
SHA:688613 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | -3.61 | -12.66 | 54.23 | 95.22 | 120.78 | 88.94 | Upgrade |
Depreciation & Amortization | 18.35 | 18.35 | 18.04 | 18.03 | 13.17 | 12.64 | Upgrade |
Other Amortization | 6.46 | 6.46 | 4.87 | 2.28 | 1.58 | 0.08 | Upgrade |
Loss (Gain) From Sale of Assets | -0.64 | -0.64 | - | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | -0.2 | -0.2 | -0.08 | 0.32 | 0.01 | - | Upgrade |
Loss (Gain) From Sale of Investments | -17.92 | -17.92 | -18.02 | -10.23 | -14.92 | -4.52 | Upgrade |
Provision & Write-off of Bad Debts | 9.23 | 9.23 | 1.42 | 0.61 | 0.48 | -0.1 | Upgrade |
Other Operating Activities | 5.64 | -1.4 | 1.86 | -1.71 | 1.8 | -0.36 | Upgrade |
Change in Accounts Receivable | -21.15 | -21.15 | -30.39 | -12.16 | -9.52 | -9.24 | Upgrade |
Change in Inventory | -22.35 | -22.35 | -12.71 | 0.71 | 1.83 | -14.61 | Upgrade |
Change in Accounts Payable | 25.79 | 25.79 | 38.52 | 11.81 | 16.22 | 18.12 | Upgrade |
Operating Cash Flow | -3.51 | -19.6 | 51.68 | 102.05 | 129.76 | 84.88 | Upgrade |
Operating Cash Flow Growth | - | - | -49.36% | -21.35% | 52.89% | -4.04% | Upgrade |
Capital Expenditures | -20.74 | -13.43 | -21.9 | -45.42 | -61.22 | -56.4 | Upgrade |
Sale of Property, Plant & Equipment | 0 | 0 | 0.21 | 0 | - | - | Upgrade |
Cash Acquisitions | -24.62 | -24.62 | - | - | - | - | Upgrade |
Investment in Securities | 25.62 | -3.63 | -96.57 | -152 | -168.8 | -101.1 | Upgrade |
Other Investing Activities | 0.2 | 55.89 | 0.19 | 0.03 | 0.53 | 14.22 | Upgrade |
Investing Cash Flow | -19.54 | 14.22 | -118.08 | -197.39 | -229.49 | -143.28 | Upgrade |
Long-Term Debt Issued | - | - | 25 | - | 47.6 | 8.23 | Upgrade |
Long-Term Debt Repaid | - | -10.69 | -40.15 | -15.67 | -56.75 | -2.6 | Upgrade |
Net Debt Issued (Repaid) | -10.5 | -10.69 | -15.15 | -15.67 | -9.15 | 5.63 | Upgrade |
Issuance of Common Stock | 14.71 | 22.52 | - | - | 508.33 | - | Upgrade |
Common Dividends Paid | -0.63 | -10.78 | -17.06 | -40.12 | -1.24 | -1.4 | Upgrade |
Other Financing Activities | -2.77 | - | - | - | -7.73 | - | Upgrade |
Financing Cash Flow | 0.8 | 1.05 | -32.22 | -55.79 | 490.21 | 4.23 | Upgrade |
Foreign Exchange Rate Adjustments | 0.2 | -0.2 | 0 | -0.3 | 0 | -0.13 | Upgrade |
Net Cash Flow | -22.05 | -4.54 | -98.62 | -151.43 | 390.49 | -54.31 | Upgrade |
Free Cash Flow | -24.26 | -33.03 | 29.78 | 56.63 | 68.54 | 28.47 | Upgrade |
Free Cash Flow Growth | - | - | -47.42% | -17.38% | 140.72% | 151.87% | Upgrade |
Free Cash Flow Margin | -11.35% | -16.03% | 13.15% | 23.09% | 29.04% | 15.50% | Upgrade |
Free Cash Flow Per Share | -0.16 | -0.23 | 0.23 | 0.42 | 0.57 | 0.28 | Upgrade |
Cash Interest Paid | 1.75 | - | - | - | - | - | Upgrade |
Cash Income Tax Paid | 25.84 | 22.93 | 16.52 | 10.57 | 20.5 | 16.05 | Upgrade |
Levered Free Cash Flow | -12.2 | -22.86 | 18.41 | 5.93 | 11.95 | -24.64 | Upgrade |
Unlevered Free Cash Flow | -10.62 | -21.02 | 20.36 | 7.09 | 14.09 | -23.84 | Upgrade |
Change in Working Capital | -20.84 | -20.84 | -10.65 | -2.47 | 6.86 | -11.8 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.